Genes modulated by histone acetylation as new effecters of butyrate activity

被引:116
作者
Della Ragione, F
Criniti, V
Della Pietra, V
Borriello, A
Oliva, A
Indaco, S
Yamamoto, T
Zappia, V
机构
[1] Univ Naples Federico II, Sch Med, Dept Biochem & Biophys F Cedranglo, I-80138 Naples, Italy
[2] Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan
来源
FEBS LETTERS | 2001年 / 499卷 / 03期
关键词
butyrate; trichostatin A; histone hyperacetylation; histone deacetylase; GATA-2; tob-1;
D O I
10.1016/S0014-5793(01)02539-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A wealth of evidence correlates the chemopreventive activity of a fiber-rich diet with the production of butyrate, In order to identify tbe genes transcriptionally modulated by the molecule, we analyzed the expression profile of butyrate-treated colon cancer cells by means of cDNA expression arrays, Moreover, the effect of trichostatin A, a specific histone deacetylase inhibitor, was studied, A superimposable group of 23 genes out of 588 investigated is modulated by both butyrate and trichostatin A, Among them, a major target was tob-1, a gene involved in the control of cell cycle. toh-l is also upregulated by butyrate in a neuroblastoma-derived cell line, and its overexpression in the colon cells caused growth arrest. Our findings represent an extensive analysis of genes modulated by butyrate and identify completely new effecters of its biological activities. (C) 2001 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:199 / 204
页数:6
相关论文
共 45 条
  • [1] p21WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
    Archer, SY
    Meng, SF
    Shei, A
    Hodin, RA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) : 6791 - 6796
  • [2] COMPARISON BETWEEN THE EFFECT OF BUTYRIC-ACID AND ITS PRODRUG PIVALOYLOXYMETHYLBUTYRATE ON HISTONES HYPERACETYLATION IN AN HL-60 LEUKEMIC-CELL LINE
    AVIRAM, A
    ZIMRAH, Y
    SHAKLAI, M
    NUDELMAN, A
    REPHAELI, A
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1994, 56 (06) : 906 - 909
  • [3] Beck GR, 2001, CELL GROWTH DIFFER, V12, P61
  • [4] BOFFA LC, 1981, J BIOL CHEM, V256, P9612
  • [5] BURKITT DP, 1971, CANCER, V28, P3, DOI 10.1002/1097-0142(197107)28:1<3::AID-CNCR2820280104>3.0.CO
  • [6] 2-N
  • [7] Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types
    Dasen, JS
    O'Connell, SM
    Flynn, SE
    Treier, M
    Gleiberman, AS
    Szeto, DP
    Hooshmand, F
    Aggarwal, AK
    Rosenfeld, MG
    [J]. CELL, 1999, 97 (05) : 587 - 598
  • [8] DEHAAN JB, 1986, CANCER RES, V46, P713
  • [9] DELLARAGIONE F, 1995, ONCOGENE, V10, P827
  • [10] Faller D V, 1995, Curr Opin Hematol, V2, P109